DIRS.INFO The most relevant business & tech news

☆ JPMorgan says this new player in the GLP-1 market could rally 45%
▼ + stars: | 2024-09-11 | by ( Brian Evans | ) www.cnbc.com time to read: +2 min

JPMorgan thinks Viking Therapeutics could be the next big name in the GLP-1 boom. Investors are awaiting more details about the oral version, expected in early November, as a possible catalyst for the stock. VKTX YTD mountain Viking Therapeutics stock. Some patients who take these popular obesity drugs suffer nausea and gastrointensinal effects that force them to stop treatment. Oral drugs also tend to be cheaper and easier to manufacture.

Persons: GLP, Eli Lilly, Viking, Hardik Parikh, Parikh, Wegovy, Eli Lilly's Zepbound Organizations: JPMorgan, Viking, Therapeutics, Novo Nordisk, Investors, Viking Therapeutics

☆ Buy levels for 3 industrial stocks that benefit from the AI boom and sector megatrends
▼ + stars: | 2024-09-06 | by ( Zev Fima | ) www.cnbc.com time to read: +9 min

Like Thursday's look at buy levels for our four 1-rated megacaps — Amazon , Meta Platforms , Microsoft , and Nvidia — we like the business prospects of those industrial names and think their stocks will move higher over time. Here's a look at key technicals in their stock charts that signal attractive buy levels. By now, members likely know that the two levels we are always going to watch are the 50-day moving average and the 200-day. That puts a first buy level at just over $80 apiece , right at the 50-day moving average and around current levels. That said, a move below $170 would represent a breakdown below the 200-day moving average.

Persons: Eaton, we've, Jim Cramer's, DOV, ETN, Jim Cramer, Jim, Jason Marz Organizations: Microsoft, Nvidia, DuPont, Dover, CNBC Locations: Dover

☆ CEO of India's Biocon discusses first-quarter results
▼ + stars: | 2024-08-12 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCEO of India's Biocon discusses first-quarter resultsPeter Bains, group CEO of the biopharmaceutical company, outlines its growth outlook.

Persons: India's Biocon, Peter Bains

☆ China's city dwellers will soon have more pets than toddlers, and there's one way investors can cash in on the trend, Goldman Sachs says
▼ + stars: | 2024-08-05 | by ( Kwan Wei Kevin Tan | Aditi Bharade | ) www.businessinsider.com time to read: +6 min

Read previewChina's baby bust could see its urban pet population outnumbering the number of toddlers by 2030, investment bank Goldman Sachs wrote in a July 28 report. According to Goldman Sachs' forecasts, China will have more than 70 million urban pets by 2030. AdvertisementThe rise in pet ownership, the bank said, could help push China's pet food market to $12 billion by 2030. People having more pets than babies shouldn't be surprising considering how China is presently grappling with a demographic crisis. China's population shrank again in 2023, with the number of deaths exceeding the number of births by 2.08 million people.

Persons: —, Goldman Sachs, Lin Zhang, Zhang, Zheng Mu, Zheng, Cash, haven't, Bihan Chen, Emily Huang, Huang, Ann, Hunter van Kirk Organizations: Service, Business, country's National Bureau of Statistics, University of New, Zhang, National University of Singapore, National Association of Realtors, NAR, Bloomberg Intelligence Locations: China, country's, University of New Hampshire, Europe, East Asia

☆ Forget Big Tech — stocks like these have the biggest upside potential in a volatile market, investor says
▼ + stars: | 2024-07-31 | by ( Weizhen Tan | ) www.cnbc.com time to read: +3 min

"A big tech stock reckoning and correction is inevitable," the chief investment officer told CNBC's " Street Signs Asia " on Tuesday. Calling the euphoria around Big Tech stocks this year "absurd," he said that such excessive investor sentiment and "overdone" momentum "always ends the same." "The biggest risk for the stock market right now is excessive valuations. Such sectors include health care, consumer staples, utilities, and the midstream part of the energy sector, according to him. "The consumers staples sector is being overlooked right now in the market as investors chase returns in the tech sector," he added.

Persons: David Bahnsen, CNBC's, Bahnsen, Mills Organizations: Big Tech, Electric, Gilead Sciences, Mills . American Electric Power, Food Locations: United States, Biopharmaceutical, Gilead

☆ Stocks making the biggest moves midday: Ford, Viking Therapeutics, ServiceNow and more
▼ + stars: | 2024-07-25 | by ( Sean Conlon | ) www.cnbc.com time to read: +6 min

Ford posted adjusted earnings per share of 47 cents compared to the consensus forecast of 68 cents, according to LSEG. Edwards also reported second-quarter adjusted earnings of 70 cents a share, a penny above expectations, per LSEG. Honeywell — Shares moved more than 4% lower after the industrial giant's full-year outlook missed analysts' expectations. According to LSEG, analysts were expecting earnings to come in at $2.20 per share on $15.62 billion in revenue. Northrop Grumman — The defense stock climbed more than 5% after the company beat second-quarter earnings expectations.

Persons: Ford, Molina, FactSet, Edwards Lifesciences, Edwards, CJ Desai, LSEG, RTX, AbbVie, Northrop Grumman, —, Alex Harring, Yun Li, Pia Singh, Hakyung Kim, Jesse Pound Organizations: Ford, Viking Therapeutics, U.S . Army . American Airlines, American Airlines, Honeywell —, Southwest Airlines —, Southwest, Citi, Hasbro, Revenue, Machines, Business Machines, Nasdaq

☆ Stocks making the biggest moves premarket: American Airlines, Honeywell, RTX, Ford and more
▼ + stars: | 2024-07-25 | by ( Hakyung Kim | ) www.cnbc.com time to read: +7 min

Southwest reported 58 cents in adjusted earnings per share on $7.35 billion of revenue. Analysts surveyed by LSEG were looking for a profit of 51 cents per share on $7.32 billion in revenue. RTX reported $1.41 earnings per share, ex-items, compared to analysts' estimate of $1.30 per share, according to LSEG. KLA reported adjusted earnings of $6.60 per share, higher than analysts' expectations of $6.15 per share, according to LSEG. Ford reported adjusted earnings per share of 47 cents, significantly less than the consensus forecast of 68 cents, per LSEG.

Persons: oversupply, overshadowing, AbbVie, Dow, LSEG, Northrop Grumman, Dr Pepper, ServiceNow, CJ Desai, Molina, FactSet, Edwards, Ford, —, Yun Li, Jesse Pound, Christina Cheddar Berk, Fred Imbert Organizations: Airlines —, American Airlines, Honeywell —, Southwest Airlines —, Hasbro, IBM, Northrop, LSEG, Nasdaq, KLA Corporation, U.S . Army, Molina Healthcare, Technology, Ford, Viking Therapeutics Locations: LSEG

☆ Citi says take profits in AI 'highfliers,' gives safe alternatives if tech shares start to fall
▼ + stars: | 2024-07-09 | by ( Samantha Subin | ) www.cnbc.com time to read: +2 min

It's time for investors to consider taking profits in some high-flying artificial intelligence names, according to Citi. The value of AI linchpin Nvidia has more than doubled year to date, while Super Micro Computer has tripled. Given this backdrop, Pettit recommends investors take profits in popular AI names — most notably the enabler stocks like semiconductors — and allocate funds "across the theme's value chain." MCD YTD mountain Shares this year Several popular consumer staples stocks are in the basket, including Kraft Heinz and J.M. Hartford Financial Services Group is the most negatively correlated stock in the basket, with shares up 25% this year.

Persons: propping, Drew Pettit, Pettit, Kraft Heinz, J.M, Chubb Organizations: Citi, Nvidia, Gilead Sciences, Hartford Financial Services, Allstate, Honeywell, Exxon Mobil . Correction Locations: Biopharmaceutical

☆ Companies besides tech can reach megacap status, Jim Cramer says
▼ + stars: | 2024-07-08 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

CNBC's Jim Cramer on Monday suggested that it is not just Big Tech that has the capacity to lead the market. Cramer highlighted Eli Lilly , a pharmaceutical giant whose stock hit a new high during Monday's session and is currently valued at about $870 billion. "These companies maintain their status through invention," Cramer said of huge names such as Amazon , Meta , Apple , Microsoft , Alphabet and Nvidia . The question is why other companies aren't doing the same things that Eli Lilly's doing to get in the winner's circle." Eli Lilly did not immediately respond to CNBC's request for comment.

Persons: CNBC's Jim Cramer, Cramer, Eli Lilly, Eli Lilly's, Eli Lilly's Alzheimer's, — Organizations: Big Tech, U.S . Food, Drug Administration, Apple, Microsoft, Nvidia Locations: U.S

☆ Stocks making the biggest moves midday: Paramount Global, Morphic Holding, Ideaya Biosciences and more
▼ + stars: | 2024-07-08 | by ( Sean Conlon | ) www.cnbc.com time to read: +3 min

Skydance and its financial backers will invest more than $8 billion into Paramount and to acquire National Amusements, Paramount's controlling shareholder. Morphic Holding – Shares rallied 75% on news that Eli Lilly will acquire the biopharmaceutical company in a $3.2 billion deal . The deal will give Eli Lilly access to Morphic's portfolio of treatments in development, such as those for ulcerative colitis and Crohn's disease. Shares of Eli Lilly advanced 1.3% on the news. Boeing – Shares fell slightly after the airplane maker agreed to plead guilty to criminal fraud related to the fatal 737 Max crashes, sparing Boeing from a trial.

Persons: Eli Lilly, BofA, Corning, Guggenheim, Max, Grayson, Raymond James, Samantha Subin, Pia Singh, Hakyung Kim, Sarah Min, Michelle Fox Organizations: Paramount Global, Skydance Media, Skydance, Paramount, National, Morphic, Ideaya Biosciences, Bank of America, Boeing –, Boeing, ., CNBC, Devon Energy, Gilead Sciences Locations: Columbia, Stifel, Williston, Gilead

☆ Stocks making the biggest moves premarket: Walgreens, Levi Strauss, Micron and more
▼ + stars: | 2024-06-27 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +2 min

Micron — Shares slipped nearly 6% after the semiconductor manufacturer posted revenue guidance of $7.6 billion for its current quarter, coming in line with analyst expectations. Walgreens Boots Alliance — Shares tumbled more than 11% after the retail pharmacy company reported a third-quarter earnings miss and cut its full-year adjusted profit outlook. Goldman Sachs — The U.S. banking stock slipped nearly 2% after the latest round of stress test results . However, the company reported EBITDA guidance for its fiscal year 2025 that was 5% lower than analyst consensus estimates, according to FactSet. U.S. Bancorp — The bank stock slipped more than 1% following a downgrade to neutral from overweight at J.P. Morgan.

Persons: Levi Strauss, Suzano, Walgreens, Goldman Sachs, Morgan, Vivek Juneja, — CNBC's Michelle Fox, Alex Harring, Fred Imbert Organizations: Micron, GSK —, Centers for Disease Control, LSEG, Walgreens, Federal Reserve, . U.S, Bancorp Locations: U.S, .

☆ Why Americans Hate Their Jobs; Fake Email Jobs, Meaningless Work
▼ + stars: | 2024-06-26 | by ( Molly Lipson | ) www.businessinsider.com time to read: +11 min

The American Psychological Association highlights findings that people who find their jobs meaningful are more engaged, show up to work more, and are healthier. Many in those industries have begun to refer to their work as "fake email jobs" — office jobs that largely involve sending emails without producing anything. Other people have managed to juggle multiple full-time remote jobs thanks to the limited amount of work each job actually required. Working a useless job is a "profound psychological violence," Graeber wrote, one that removes any sense of dignity and fosters "deep rage and resentment." Short of everyone quitting to become their own CEO, employers will need to figure out how to make work feel meaningful for their staff.

Persons: it's, Zers, Pew, Gen Zers, I've, Graeber, David Graeber, Simon Walo, —, Walo, Brendan Burchell, Burchell, Clay Routledge, Routledge Organizations: Pew Research, American Psychological Association, University of Zurich, University of Cambridge Locations: Italy, Spain, Sweden

☆ Stocks making the biggest moves before the bell: Robinhood, Nvidia, Lululemon, Five Below and more
▼ + stars: | 2024-06-06 | by ( Alex Harring | ) www.cnbc.com time to read: +4 min

Five Below told investors to expect between $830 million and $850 million, while analysts polled by LSEG forecasted $883 million. Sprinklr — The business technology stock dove 21.1% in the wake of weak guidance for the current quarter and full year. StoneCo — The financial technology stock rose 2.6% following an upgrade to overweight from neutral by JPMorgan . Ultragenyx Pharmaceutical — The biopharma stock added nearly 4% following an upgrade to buy from neutral at Goldman Sachs. Shopify — The e-commerce technology stock slipped 1.6% on the back of a MoffettNathanson downgrade to neutral from buy.

Persons: Goldman Sachs, Smartsheet, LSEG, Sprinklr, Mizuho, there's, StoneCo, CH Robinson, Goldman, ISI's, Shopify, Guggenheim, —, Jesse Pound, Michelle Fox, Lisa Kailai Han Organizations: Nvidia, LSEG, Revenue, Mizuho, JPMorgan, Ultragenyx Pharmaceutical, Goldman, eBay, Citi, UBS, BMO Capital, BMO, Viridian Therapeutics, ISI, Energy Locations: Americas

☆ We're buying more shares of this industrial company with data center and health-care exposure
▼ + stars: | 2024-06-05 | by ( Jeff Marks | ) www.cnbc.com time to read: +3 min

Dover shares hit a rough patch this week, falling alongside many other industrials on concerns about the health of manufacturing after the release of soft PMI numbers Monday. Dover makes thermal connectors used in the liquid cooling of data centers, a process growing in popularity due to AI. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer's, DOV, Jim Cramer, Jim Organizations: Dover, Federal, CNBC Locations: Dover, Illinois

☆ The incredible oblivion of Judge Marvin Isgur
▼ + stars: | 2024-06-03 | by ( Dakin Campbell | ) www.businessinsider.com time to read: +45 min

On a mild Houston day in March 2021, Judge Marvin Isgur prepared to oversee the only case on his docket that morning. In October 2023, the Fifth Circuit Court rebuked Judge David Jones but said that his longtime colleague, Judge Marvin Isgur, had been "unaware" of Jones' inappropriate relationship. "But only Judge Isgur knows what he knew or didn't know about the relationship." Much of this work was in cases before either Judge Isgur or Judge Jones. Isgur can continue to hear the case, he ruled, writing in the December 2023 opinion that lawyers for the creditor "failed to demonstrate much other than that former Judge Jones and Judge Isgur are close friends."

Persons: Marvin Isgur, David Jones, Jones, Elizabeth Freeman, Jackson Walker, Isgur, Michael Van Deelen, he'd, Freeman, Matthew Cavenaugh, Cavenaugh, Michael Van Deelen Van, Judge Jones, who'd, Steve Smith, Smith, Michael Lewis, Van Deelen, I'm, Van Deelen's, Tom Kirkendall, Gary Cruciani, Judge David Jones, Nancy Rapoport, University of Nevada Las Vegas William S, Kirkendall, " Jones, Trump, she's, Sarah, Porter Hedges, —, — Elizabeth Freeman, John Higgins, Whitney Ables, Josh Wolfshohl, Amy Lucas, Porter, Wesley Steen, Fifth Circuit —, that's, Liz, Bruce Markell, it's, Judge William Greendyke, Lynn LoPucki's, Patricia Tomasco, Christopher Lopez, Manges, Greendyke, Albert Alonzo, Alonzo, Jones Isgur, Susan Tran Adams, Matt Cavenaugh, Veronica Polnick, Genevieve Graham, cookout, Graham, Tran, Christina Morrison, David, I, Neiman Marcus, J.C, Penney, Freeman hadn't, hadn't, Jim Wilkinson, Ellis, Kirkland, Ellis —, Veronica Polnick —, Polnick —, Elizabeth, COVID, Jackson, Kirkland Ellis, they'd, — Greendyke, Wilkinson, Judge Isgur, Mike Warner, Eduardo Rodriguez, Rodriguez, Isgur's, Judge Lopez —, Lopez, Alfredo Perez, Weil, Perez, Richard Schmidt, Jack Newsham Organizations: Business, Southern District of, McDermott International, Southern, Houston, Fifth Circuit, Appeals, Department of Justice, Fifth, University of Nevada, Boyd School of Law, Circuit, University of Houston, American Bankruptcy Institute, Emory Law School, Emory, Facebook, Big Law, Reuters, Bloomberg, Northwestern's Pritzker School of Law, Enron, LinkedIn, Southern District of Texas, Judicial Conference, Texas, Chesapeake Energy, Big, Kirkland, Cavenaugh, UPS, Technologies, Candy Club, Omni, Norton Rose, GWG Holdings Inc, Brands, Southern District's, Southern District, US, Former Locations: Texas, Southern District, Southern District of Texas, Houston, New Orleans, United States, University of Nevada Las Vegas, Kirkendall, Galveston, Carolina, Porter, Harris, Nevada, Southern District of Texas , Delaware, New York, Delaware, Weil, Southern, disgorge, Sorrento, Corpus Christi, prefacing

☆ Salesforce is the most oversold stock on Wall Street amid a losing week for the markets
▼ + stars: | 2024-05-31 | by ( Hakyung Kim | ) www.cnbc.com time to read: +3 min

Dow member Salesforce dropped about 19% during the week, which made it the most oversold stock in the market. With this in mind, CNBC Pro screened for the most overbought and oversold stocks on Wall Street as measured by their 14-day relative strength index, or RSI. Stocks with a 14-day RSI below 30 are considered oversold, suggesting shares may be due for a comeback. On the other hand, a 14-day RSI higher than 70 indicates a stock is overbought and may soon pull back. Biopharmaceutical company Bristol-Myers Squibb was the second-most oversold stock of the week.

Persons: Salesforce, Goldman Sachs, Morgan Stanley, Myers Squibb, Meyers, Ralph Lauren Organizations: Federal, Nasdaq, Dow Jones, Dow, Investors, CNBC Pro, Wall Street, LSEG, Meyers Squibb, Tech, HP Locations: Bristol

☆ A corner of the cancer therapy market is heating up—Here are the names investors need to know
▼ + stars: | 2024-05-23 | by ( Michelle Fox | ) www.cnbc.com time to read: +8 min

A $25 billion market Meanwhile, RBC Capital Markets sees a $25 billion market opportunity for the space. A name Jones likes is Perspective Therapeutics , which he rates outperform. CATX 1Y mountain Perspective Therapeutics year to date Cantor Fitzgerald is also bullish on the name. So it's really an ideal profile," said Piper Sandler analyst Edward Tenthoff, who doesn't cover Perspective Therapeutics. Then there is Lantheus Holdings , which calls itself a radiopharmaceutical-focused company and has a $5.6 billion market cap.

Persons: There's, Eli Lilly, Myers, Jefferies, Andrew Tsai, radiopharma, Oppenheimer, Jeff Jones, FactSet, William Blair, Read, — it's, Andy Hsieh, Gregory Renza, Jones, Cantor Fitzgerald, Louise Chen, it's, Piper Sandler, Edward Tenthoff, Dan Lyons, Janus Henderson, Lantheus, Roanna Ruiz Organizations: Novartis, pharma, Mariana Oncology, Myers Squibb, AstraZeneca, Fusion Pharmaceuticals, RBC Capital Markets, TRT, Therapeutics, Alpha, Janus, Janus Henderson Investors, Lantheus Holdings, Lantheus, Leerink, ~$ Locations: Biopharma, Bristol, Mariana, radiopharma, New Jersey

☆ Stocks making the biggest moves midday: Nvidia, Boeing, Live Nation Entertainment and more
▼ + stars: | 2024-05-23 | by ( Sarah Min | ) www.cnbc.com time to read: +3 min

Nvidia — The chipmaker and artificial intelligence beneficiary spiked 11% after Nvidia posted strong fiscal first-quarter results , issued better-than-expected guidance and announced a 10-for-1 stock split. Live Nation Entertainment — Shares dropped 7% after the U.S. Department of Justice sued to break up the parent company of Ticketmaster, alleging antitrust violations . The cosmetics maker posted fourth-quarter adjusted earnings of 53 cents per share on revenues of $321.1 million. Snowflake had posted $829 million in revenue, surpassing the consensus forecast of $786 million, per LSEG. Adjusted earnings for the period came in at 14 cents a share, however, falling short of analysts' consensus estimate by 4 cents.

Persons: Brian West, LSEG, LiveRamp, GoodRx, Snowflake, Goldman Sachs, Morgan Stanley, — CNBC's Michelle Fox, Pia Singh Organizations: Nvidia, Micro Computer, Boeing —, Boeing, U.S . Department of Justice, Ticketmaster, RBC, Taiwan Semiconductor Manufacturing, Taiwan Semiconductor, Machinery, Titan Machinery, Triumph, JPMorgan, Corp, LSEG, Revenue

☆ This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
▼ + stars: | 2024-05-23 | by ( Michelle Fox | ) www.cnbc.com time to read: +7 min

RBC Capital Markets sees a $25 billion market opportunity for the space. The average analyst rating is hold, with 8% upside to the average analyst price target, according to FactSet. Eli Lilly has an average analyst rating of overweight and 8.3% upside to the average analyst price target, according to FactSet. Stock Chart Icon Stock chart icon AstraZeneca's one-year performanceAstraZeneca shares have an average analyst rating of overweight and nearly 6% upside to the average analyst price target, according to FactSet. Stock Chart Icon Stock chart icon Bristol-Myers Squibb's one-year performance

Persons: It's, Gregory Renza, Renza, Oppenheimer, Jeff Jones, Piper Sandler, Edward Tenthoff, Eli Lilly, Dan Lyons, Janus Henderson, Myers Squibb, William Blair, Matt Phipps, Jefferies, Andrew Tsai, They've, Janus Henderson's Lyons, Jones, Piper Sandler's Tenthoff, Myers Organizations: pharma, RBC Capital Markets, TRT, Novartis, Mariana Oncology, Janus, Janus Henderson Investors, Bristol, RayzeBio, Karuna Therapeutics, AstraZeneca, Fusion Pharmaceuticals, GlobalData's Pharma Intelligence, Pluvicto Locations: Mariana, Bristol

☆ Stocks making the biggest moves before the bell: NVDA, LYV, SNOW
▼ + stars: | 2024-05-23 | by ( Alex Harring | ) www.cnbc.com time to read: +4 min

Snowflake posted $829 million in revenue, while analysts polled by LSEG had called for $786 million. Adjusted earnings for the period came in at 14 cents a share, however, missing the consensus estimate by 4 cents. Beauty — The cosmetics maker added 3.4% after easily surpassing consensus forecasts from analysts surveyed by FactSet for the fiscal fourth quarter. posted 53 cents in earnings per share, excluding items, on $321.1 million in revenue, while analysts penciled in just 33 cents on $292.6 million in revenue. On top of that, LiveRamp offered firm revenue guidance for both the current quarter and full year.

Persons: Snowflake, LSEG, NetEase, FactSet, e.l.f, LiveRamp, Cytokinetics, Goldman Sachs, Morgan Stanley, Ed Bred, Lori Koch, Alibaba, GoodRX, —, Jesse Pound, Pia Singh, Yun Li, Tanaya Macheel, Sarah Min, Michelle Fox Organizations: Nvidia, Micro, Taiwan Semiconductor, Bloomberg, Department of Justice, of, News, Corp, JPMorgan, DuPont de Nemours, DuPont, Bloomberg News, Bank of America, RBC, Hasbro —, Hasbro Locations: Southern, of New York, —

☆ Stocks making the biggest moves after hours: Nvidia, Snowflake, VF Corp. and more
▼ + stars: | 2024-05-22 | by ( Samantha Subin | ) www.cnbc.com time to read: +3 min

Check out the companies making headlines after the bell : Nvidia — The chipmaker added about 4% after announcing a 10-for-1 stock split . Nvidia also surpassed Wall Street's fiscal first-quarter estimates on the top and bottom lines, and it issued strong guidance for the current quarter. Fiscal first-quarter revenue surpassed the Street's expectations, coming in at $829 million, versus consensus estimates for $786 million, per LSEG. — The apparel and footwear company sank 9% after posting an unexpected loss for the recent quarter and revenue that fell short of Wall Street's estimates. VF Corp. posted a loss of 32 cents per share on $2.37 billion in revenue.

Persons: LSEG, FactSet, Synopsys, LiveRamp, Dow Jones, Goldman Sachs, Morgan Stanley, Ed Breen, Lori Koch, Breen, —, Darla Mercado, Sarah Min, Scott Schnipper, Christina Cheddar, Berk Organizations: Nvidia, Super Micro, Devices, Corp, VF Corp, LiveRamp Holdings, News Corp, JPMorgan, DuPont de Nemours, DuPont

☆ Stocks making the biggest moves midday: Walgreens, GameStop, Intel, Robinhood and more
▼ + stars: | 2024-05-13 | by ( Pia Singh | ) www.cnbc.com time to read: +3 min

GameStop — Shares in the video game retailer soared more than 65% on Monday after "Roaring Kitty," the man who fueled the 2021 GameStop mania, posted online on Reddit for the first time in roughly three years. Reddit , Robinhood — Shares of the two companies that were involved with the meme stock mania in 2021 rose on Monday as GameStop surged. Reddit rose more than 9%, hitting its highest level since March, while retail brokerage stock Robinhood gained about 6.2%. Intel — The chipmaker gained nearly 4% after The Wall Street Journal reported that it is in talks for an $11 billion deal with Apollo Global Management to build a factory in Ireland. Airlines — American Airlines gained 4.4%, while United Airlines and Delta Air Lines added 2.9% and 1.7%, respectively, after HSBC initiated coverage with buy ratings.

Persons: Incyte, Morgan Stanley, —, Alex Harring, Brian Evans, Hakyung Kim, Jesse Pound Organizations: Walgreens, Alliance, Bloomberg, GameStop, Arm Holdings, Nikkei, Nexstar Media Group, CW, Intel, Street Journal, Apollo Global Management, Technologies, Susquehanna, Airlines — American Airlines, United Airlines, Delta Air Lines, HSBC, Delta Locations: Irving, Texas, Ireland

☆ Stocks making the biggest moves premarket: GME, NVDA, INTC, KVUE
▼ + stars: | 2024-05-13 | by ( Hakyung Kim | ) www.cnbc.com time to read: +2 min

Kenvue — Shares declined nearly 2% after Kenvue announced Johnson & Johnson will sell its 9.5% stake stake in the company. The consumer health company completed its spinoff from Johnson & Johnson in May 2023. The company's balance sheet deterioration was also a point of concern for the stock, according to the firm. Demand for international travel and a rebound in corporate travel will support the stocks, according to the firm. Incyte — The biopharmaceutical company jumped more than 5% Monday after it approved a $2 billion share repurchase program.

Persons: Kitty, Jefferies, Blayne Curtis, Kenvue, Johnson, Squarespace, Penn, Susquehanna, —, Samantha Subin, Jesse Pound, Michelle Fox, Pia Singh, Fred Imbert Organizations: GameStop, Arm, Nikkei, Nvidia, Intel, Street Journal, Apollo Global Management, Kenvue, Johnson, Penn Entertainment, Bank of America, Airline, American Airlines, HSBC, Delta, Susquehanna Locations: Ireland, Delta

☆ AstraZeneca to withdraw Covid vaccine worldwide, citing a drop in demand
▼ + stars: | 2024-05-08 | by ( Sophie Kiderlin | In | ) www.cnbc.com time to read: +2 min

In this photo illustration a covid-19 vaccine is seen with the AstraZeneca logo in the background. (Photo Illustration by Nikos Pekiaridis/NurPhoto via Getty Images)Pharmaceutical giant AstraZeneca on Wednesday said it planned to withdraw its Covid-19 vaccine as demand for it has declined. Demand for the Vaxzevria vaccine has tailed off as new vaccines tailored to specific Covid variants have emerged, AstraZeneca said in a statement. "As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines. Next to Covid vaccines, AstraZeneca has been working on a range of other treatments for illnesses including cancer.

Persons: Nikos Pekiaridis Organizations: AstraZeneca, Getty Images, Pharmaceutical, University of Oxford, Covid, World Health Organization, European Union, Fusion Pharmaceuticals Inc Locations: U.K

☆ This rare muscle disease play can rally more than 50%, BofA says
▼ + stars: | 2024-05-03 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

Avidity Biosciences stock has more room to run thanks to the company's pipeline of multiple treatments for rare muscle disorders, according to Bank of America. Avidity has a therapeutic platform — antibody oligonucleotide conjugates — that was well-received at the time it went public in 2020, Meacham said. But shares were hurt by a clinical hold on Avidity's leading program for treating an uncommon muscle disorder, DM1. The program, tested in the Marina trial, recently saw long-term data that has "helped lift that key overhang on the stock," Meacham said. Those catalysts are tied to two other drugs in the muscle disorder space that are expected to report data this year, according to Meacham.

Persons: Geoff Meacham, Meacham Organizations: Biosciences, Bank of America Locations: San Diego, Thursday's

Search resuls for: "biopharmaceutical"

25 mentions found